Also see: Accenture, JetBlue: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES

Agilent ( A - Get Report) estimates, target increased at Jefferies. A estimates were raised through 2012, Jefferies said. Company is delivering higher organic growth and generating solid cash flow. Buy rating.

Apache ( APA - Get Report) estimates, target raised at Morgan Stanley. Shares of APA now seen reaching $150, according to Morgan Stanley. Estimates also increased, as the company is positioned well for growth in 2012. Overweight rating.

Darling ( DAR - Get Report) estimates, target boosted at Goldman. Shares of DAR now seen reaching $20, according to Goldman Sachs. Estimates also upped, as the company is seeing better pricing. Buy rating.

DryShips ( DRYS) estimates, target reduced at Goldman. Shares of DRYS now seen reaching $5.50, according to Goldman Sachs. Estimates also cut, as the company is facing higher expenses and a higher share count. Neutral rating.

Forest Laboratories ( FRX) numbers raised at Jefferies. Shares of FRX now seen reaching $42, according to Jefferies. Estimates also increased, given expectations for a solid launch of Daliresp. Buy rating.

Gannett ( GCI) estimates lowered at UBS through 2012. Checks show lower television and national print advertising demand. Neutral rating and $16 price target.

MasterCard ( MA - Get Report) estimates, target boosted at Argus. Shares of MA now seen reaching $325, according to Argus Research. Estimates also upped. Buy rating.

Merck ( MRK - Get Report) estimates, target upped at Goldman. MRK estimates were boosted through 2015, Goldman Sachs said. New hepatitis treatment will add to earnings. Neutral rating and new $40 price target.

Sandisk ( SNDK) target increased at Morgan Stanley to $70. Company is seeing better demand across the board. Overweight rating.

End of report.

This article was written by a staff member of TheStreet.